In this study, we showed an NF-κB-independent role of Bcl-3 in the liver, and our work suggests deletion of Bcl-3 greatly ameliorates TNF-induced liver injury, which provides a potential therapeutic target for various liver diseases. Here, BCL3 is linked to liver disorder.